Nanoradiopharmaceuticals for breast cancer imaging: development, characterization, and imaging in inducted animals

Monoclonal antibodies as polymeric nanoparticles are quite interesting and endow this new drug category with many advantages, especially by reducing the number of adverse reactions and, in the case of radiopharmaceuticals, also reducing the amount of radiation (dose) administered to the patient. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarcinelli, Michelle Alvares, Albernaz, Marta de Souza, Szwed, Marzena, Iscaife, Alexandre, Leite, Kátia Ramos Moreira, Junqueira, Mara de Souza, Bernardes, Emerson Soares, da Silva, Emerson Oliveira, Tavares, Maria Ines Bruno, Santos-Oliveira, Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045224/
https://www.ncbi.nlm.nih.gov/pubmed/27713638
http://dx.doi.org/10.2147/OTT.S110787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045224/
https://www.ncbi.nlm.nih.gov/pubmed/27713638
http://dx.doi.org/10.2147/OTT.S110787

Ejemplares similares